Results 271 to 280 of about 55,803 (311)

Intravenous Immunoglobulin

JAMA, 1990
openaire   +1 more source

Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial

Lancet, The, 2022
Urs Fischer, Johannes Kaesmacher, Marc Ribo   +2 more
exaly  

[Intravenous immunoglobulins].

Bulletin de l'Academie nationale de medecine, 2013
openaire   +3 more sources

Intravenous Immunoglobulin

2015
Francisco Kerdel, Luis Dehesa
openaire   +1 more source

Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials

Lancet, The, 2023
exaly  

[Intravenous immunoglobulin therapy].

La Revue du praticien, 2005
Intravenous immunoglobulins (IVIg) are therapeutic preparations of normal human IgG that are obtained from pools of healthy blood donors. They can be used at low dose in the substitutive therapy of patients with primary or secondary immune deficiencies, or at high dose as an immunomodulatory agent in a large number of autoimmune and/or systemic ...
openaire   +1 more source

Intravenous immunoglobulins

Transfusion Science, 1992
openaire   +1 more source

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

Lancet, The, 2010
Rüdiger von Kummer, Danilo S Toni, James C Grotta   +2 more
exaly  

Intravenous Immunoglobulin

1989
A. C. Newland, P. A. Veys
openaire   +1 more source

Intravenous versus subcutaneous immunoglobulin

The Lancet Neurology, 2018
Ravi, Uniyal, Ravindra Kumar, Garg, Hardeep Singh, Malhotra, Neeraj, Kumar, Shweta, Pandey   +4 more
openaire   +2 more sources